BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28503558)

  • 1. Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?
    Koay EJ; Odisio BC; Javle M; Vauthey JN; Crane CH
    Hepatobiliary Surg Nutr; 2017 Apr; 6(2):105-116. PubMed ID: 28503558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional Radiology Locoregional Therapies for Intrahepatic Cholangiocarcinoma.
    Woodhead G; Lee S; Struycken L; Goldberg D; Hannallah J; Young S
    Life (Basel); 2024 Feb; 14(2):. PubMed ID: 38398726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.
    Ierardi AM; Angileri SA; Patella F; Panella S; Lucchina N; Petre EN; Pinto A; Franceschelli G; Carrafiello G; Cornalba G; Sofocleous CT
    Med Oncol; 2017 Jan; 34(1):11. PubMed ID: 28008570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation dose escalation for locally advanced unresectable intrahepatic and extrahepatic cholangiocarcinoma.
    Avila S; Smani DA; Koay EJ
    Chin Clin Oncol; 2020 Feb; 9(1):10. PubMed ID: 32008331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Intrahepatic Cholangiocarcinoma.
    Kodali S; Shetty A; Shekhar S; Victor DW; Ghobrial RM
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34072277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology.
    Fabritius MP; Ben Khaled N; Kunz WG; Ricke J; Seidensticker M
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Locoregional and local ablative treatment options for liver tumors].
    Hinrichs JB; Wacker FK
    Internist (Berl); 2020 Feb; 61(2):158-163. PubMed ID: 31919532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventional radiology approaches for intra-hepatic cholangiocarcinoma.
    Mosconi C; Calandri M; Javle M; Odisio BC
    Chin Clin Oncol; 2020 Feb; 9(1):8. PubMed ID: 32008330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.
    Tao R; Krishnan S; Bhosale PR; Javle MM; Aloia TA; Shroff RT; Kaseb AO; Bishop AJ; Swanick CW; Koay EJ; Thames HD; Hong TS; Das P; Crane CH
    J Clin Oncol; 2016 Jan; 34(3):219-26. PubMed ID: 26503201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Kis B; El-Haddad G; Sheth RA; Parikh NS; Ganguli S; Shyn PB; Choi J; Brown KT
    Cancer Control; 2017; 24(3):1073274817729244. PubMed ID: 28975829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study.
    Rafi S; Piduru SM; El-Rayes B; Kauh JS; Kooby DA; Sarmiento JM; Kim HS
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):440-8. PubMed ID: 22956045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
    Sebastian NT; Tan Y; Miller ED; Williams TM; Noonan AM; Hays JL; Abdel-Misih S; Diaz DA
    JAMA Netw Open; 2019 Sep; 2(9):e1911154. PubMed ID: 31517963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in molecular targeted therapies for intrahepatic cholangiocarcinoma].
    Xie ZH; Li J; Xia Y; Shen F
    Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):289-294. PubMed ID: 32241059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiocarcinoma. Results of aggressive surgical management.
    Cherqui D; Tantawi B; Alon R; Piedbois P; Rahmouni A; Dhumeaux D; Julien M; Fagniez PL
    Arch Surg; 1995 Oct; 130(10):1073-8. PubMed ID: 7575119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma.
    Marcos-Alvarez A; Jenkins RL
    Surg Oncol Clin N Am; 1996 Apr; 5(2):301-16. PubMed ID: 9019353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma--current treatment options.
    Friman S
    Scand J Surg; 2011; 100(1):30-4. PubMed ID: 21491796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of recurrent cholangiocarcinoma.
    Slakey DP
    Am Surg; 2002 Apr; 68(4):395-7. PubMed ID: 11952256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in liver surgery for cholangiocarcinoma.
    DeOliveira ML; Kambakamba P; Clavien PA
    Curr Opin Gastroenterol; 2013 May; 29(3):293-8. PubMed ID: 23563982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
    Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.